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INTRODUCTION
The health effects of space radiation on astronauts need to be precisely quantified and controlled. Astronauts are exposed to a complex radiation field consisting of protons, heavy ions and secondary particles including neutrons with a broad range of energy.
1) The dose rate in space is much higher than that of natural radiation on the ground, and the accumulated dose during a long space mission could present a non-negligible cancer risk.
2) This risk and other biological effects in such a special environment are uncertain and need to be quantified through strategic, programmatic studies.
The major concern about the space radiation health risk is stochastic effects, that is, cancers and hereditary effects. This effect is generally quantified with the "effective dose (E)." 3, 4) The definition of E takes into account the different relative radiosensitivities of the various organs and tissues in the human body with respect to radiation detriment from stochastic effects. The E is given as the tissue-weighted sum of equivalent doses in critical organs/tissues; the equivalent dose is defined as the radiation-weighted sum of absorbed dose at each organ/tissue. For applications, however, a single wR value of 20 recommended for all types and energies of heavy charged particles is too conservative and, according to ICRP, 4) more realistic approach based on the concept of quality factor (Q), i.e., dose equivalents, may have to be employed. The Q characterizes the biological effectiveness of a radiation based on the ionization density along the tracks of charged particles in tissue and generally given as a function of the unrestricted linear energy transfer (LET).
The effective dose has only been measured once, in the STS-91 phantom torso experiment. 5) Most other studies have been devoted to describing transport processes of space radiation components using computer codes [6] [7] [8] [9] with anatomical models. 10, 11) However, the interactions of energetic space radiation, particularly high-charge and highenergy (HZE) particles of galactic cosmic radiation, are extremely complicated and uncertain. The accuracy of model prediction is desirably to be verified by measurements using a life-size human phantom onboard a spacecraft. Therefore, in this paper, the experimental procedure of the effective dose measurement in the low Earth orbit mission is briefly introduced and the results are compared with those of succeeding studies including numerical simulations. which flew at nearly the same orbit as that of the International Space Station (ISS) (inclination: 51.6°, altitude: ~400 km). 5) Organ dose equivalents were measured with combined dosimeter packages consisting of thermoluminescence dosimeters (TLD) of Mg 2 SiO 4 :Tb (MSO, Kasei Optonics, Inc.) and plastic nuclear track detectors (PNTD) of highly sensitive CR-39 (HARZLAS TD-1, Fukuvi Chemical Industry). Such small-scale dosimeters are much beneficial because they avoid disturbing the surrounding radiation field in the phantom.
In general, the efficiency of TLD changes to a large extent depending on the ionization density along the track of a particle which is often denoted as LET. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] This phenomenon has successfully been explained a priori for LiF TLDs by means of target-hit models based on the track structure theory. [24] [25] [26] [27] TLD values obtained as γ-ray equivalent absorbed doses have some errors for space radiation, and the errors have to be corrected based on experimental data obtained in ground-based studies. We thus examined responses of various TLDs and other luminescence dosimeters using protons at the Cyclotron and heavy ions at the Heavy Ion Medical Accelerator in Chiba (HIMAC) of National Institute of Radiological Sciences (NIRS). The relative efficiencies in reference to 137 Cs γ-rays are derived on the absorbed dose basis. The smoothed LET-dependent efficiency curves that were obtained from the data plots of selected dosimeters irradiated with relativistic ion beams are shown in Fig.  1 . [15] [16] [17] [18] [19] [20] [21] [22] [23] From these results, we found that MSO is the most useful TLD substance, because its efficiency is almost unity up to 10 keV μm -1 and decreases in the larger LET range that can be detected with PNTD (Fig. 3) .
The track formation sensitivities of PNTD, including their incident angle dependence, were quantified as a function of LET using heavy ion beams of NIRS-HIMAC, as shown in Fig. 3 . The strong dependence of PNTD sensitivity on incident angles was incorporated into a conservative regression curve that would not underestimate radiation doses (Fig. 3b) , adhering to radiological protection practices.
A set of three TLD and two PNTD chips was put into a case of tissue-equivalent resin. Fifty-nine detector cases were placed into or on critical organ/tissue positions of a life-size human phantom (RANDO Phantom, Alderson Research Laboratories) composed of polyurethane and a human skeleton, as indicated in Fig. 4 . The phantom was covered with a suit of heat-resistant fibers (Nomex, DuPont, Inc.), and four detector cases were put into the suit pockets both at the chest and abdomen. The phantom was fixed with [15] [16] [17] [18] [19] [20] [21] [22] [23] : TLD-Mg2SiO4:Tb (MSO), TLD-BeO:Na, TLD-7 LiF:Mg,Ti, the radiophotoluminescence dosimeter (RPLD) of a phosphate glass, the optically stimulated luminescence dosimeter (OSLD) of Al2O3:C, and the direct ion storage dosimeter (DIS-1). Most of the data were obtained using heavy ion beams at NIRS-HIMAC. Absorbed doses were evaluated based on the efficiencycorrected values of TLD as γ-ray equivalent absorbed doses (Fig. 2) , and the spectra of LET greater than 10 keV μm were estimated from the PNTD track data. Organ dose equivalents were calculated from the absorbed doses and the LET spectra according to the Q (L) function in the ICRP 1990 recommendations 3) ; details of dose determination procedures were explained in the paper 5) of the author and his colleagues. Table 1 shows the values of absorbed dose (D T ), dose equivalent (H T ), and effective quality factor (Q e ) in critical organs/tissues of the phantom torso flown in the STS-91 experiment. The absorbed doses varied by a factor of 1.6 and the dose equivalents by a factor of 1.5 among the organs and tissues. Q e ranged from 1.7 to 2.4, varying by a factor of 1.4. Summing up these organ and tissue doses weighted by the tissue weighting factors of the 1990 ICRP recommendations, 3) we calculated the effective dose (E) as 4.1 mSv for this 9.8-day mission. This E value was about 90% of the skin dose equivalent (Hskin) measured on the abdomen. About 70% of E came from five internal organs and tissues, the lung, stomach, bone marrow, colon, and gonad (testis).
COMPARISONS WITH THE RESULTS OF SUCCEEDING STUDIES
During the STS-91 mission, organ doses of the phantom torso were measured also by Badhwar et al., NASA Johnson a Bone surface is at the shoulder. The dose at the breast was measured in a Nomex-suit pocket on the chest; the skin dose was measured in another pocket on the abdomen. b The value shows a mean (m) ± one standard deviation (σ); the σ indicates a statistical error (type-A) only.
Systematic errors (type-B) of the detector system were conservatively incorporated into the values, in keeping with radiological protection practices, by using conservative calibration curves in both the correction of TLD efficiency (Fig. 2 ) and the determination of LET using PNTD (Fig. 3 ). c The Q-LET relationship and the wT values were adopted from the 1990 recommendation of ICRP, although the concept of dose equivalent was introduced in 1977 recommendations.
Space Center (NASA-JSC), using small active detectors of Si PIN diodes. 28) Table 2 shows a comparison of the absorbed doses in critical internal organs/tissues measured by Badhwar et al. to our measurements. Both sets of data agreed well, and the error is within 20%. Also, comparisons of calculations by Cucinotta et al. 29) using the HZETRN/QMSFRG transport model 30) to the measured values are shown in Table 3 . Very good agreement with less than 25% error was seen for all organs, and, regarding the effective dose, both data were in excellent agreement with only 5% difference.
Another phantom torso experiment was performed by the scientists of NASA-JSC for the ISS Increment-2 mission in 2001. In this experiment, small active Si detectors were located in critical organs of a phantom torso, as described by Badhwar et al. 28) ; in addition, a tissue equivalent proportional counter (TEPC) and a charged particle directional spectrometer (CPDS) were included on the flight. 30) Comparisons of the measurements to the calculations using the HZETRN/QMSFRG model resulted in very good agreement (Table 4) . 29) Considering the large uncertainties of biological effects, predictions of effective dose using transport models have a high level of accuracy at this time, at least for low Earth orbit missions.
We found that the dose rate obtained in the STS-91 experiment (about 0.4 mSv d -1 ) is smaller than that estimated by previous observations (0.6 to 0.8 mSv d -1 ) using a multilayer Si detector and combined CR-39/TLD methodology. 32, 33) Relatively high dose rates were observed in previous experiments using TEPC for the Space Shuttle mission. 34, 35) The dose rate, however, markedly decreased with increasing polyethylene cover thickness (Table 5) . 35 finding is favorable for controlling space radiation exposure, because it is expected that the individual dose of an astronaut could be measured conservatively on the skin surface at the breast/abdomen. It should be noted, however, that the H T values in selected radiation-sensitive organs such as the lung, stomach, gonad, and breast were not significantly different from the H skin value. A similar flat distribution of dose equivalents in a life-size phantom was observed in the ISS phantom torso experiment. 29) The data are shown in Table 4 . Organ dose equivalents at the brain, thyroid, heart, stomach, and colon were at the same level, despite the varying depths of these organs from the skin. Such a flat distribution of internal dose was not expected based on previous model calculations [34] [35] [36] ;
dose equivalents in deep organs had been predicted to be much lower than that at the skin. Although previous predictions may be true for a simplified structure like a polyethylene sphere, 35 ) the human body is surely different from such an idealized shape. The difference in findings between earlier studies and the present study suggests that operational quantities based on the ICRU sphere concept, such as the 1-cm ambient dose equivalent, may be inappropriate to apply for astronauts.
In 2007, ICRP published new recommendations 4) with new values of tissue weighting factor (w T ); the w T value of breast increased from 0.05 to 0.12; that of gonad decreased from 0.20 to 0.8; those of bladder, esophagus, liver and thyroid decreased from 0.05 to 0.04; and the value of 0.12 is given in place of 0.05 for remainder tissues, including adrenals, extrathoracic region, gall bladder, heart, kidneys, lymphatic nodes, muscle, oral mucosa, pancreas, prostate, small intestine, spleen, thymus and uterus/cervix. In order to examine the effect of these changes, wT-weighted dose equivalents for selected organs/tissues and effective dose were calculated using 2007 wT values as shown in Table 6 , compared to those obtained using 1990 wT values. It should be noted that contribution of the gonad remarkably decreased from 23% to 10%, whereas that of breast increased from 6% to 14%. As results, the effective dose slightly (about 3%) reduced from 4.1 mSv to 4.0 mSv. So far the update of wT values in 2007 does not seem to affect so Table 6 . Organ dose equivalents weighted using the 2007 tissue weighting factors (wT) 4) and effective dose for the STS-91 phantom torso experiment; the results using the 1990 tissue weighting factors are also shown for comparison.
Organ/Tissue
Organ dose equivalent (HT)
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CONCLUDING REMARKS
According to the results obtained in the past phantom torso experiments, 5, 28, 29) one would expect that the individual dose for an astronaut could be properly measured using a small personal dosimeter on the skin. To determine whether this is so, further investigation is needed on the effects of potential modifying factors such as variations of spacecraft shielding and/or orientation of a human body. Since a human body itself can work as a shielding material, the direction and posture of an astronaut should affect organ doses and could change effective dose, even at the same location in a spacecraft. Also, the balance of effective dose and specific organ doses might change depending on the solar cycle and flare events. Monitoring of solar activity changes is especially important to protect astronauts from flare particles during extravehicular activities. 36) One challenge is that we cannot know the true value of the effective dose for each astronaut. Although the author tried to develop a simple method using combined small dosimeters to determine the dose equivalent at any position in a spacecraft, 19, 37, 38) conversion from a dosimeter value to the effective dose is associated inevitably with certain uncertainties due to the complex transport phenomena of space radiation, particularly the HZE particles of galactic cosmic rays. The uncertainties need to be conservatively incorporated into the dose value in view of radiological protection, which leads to unnecessary restriction of human activities in space. Future longer missions such as moon base construction and Mars exploration will require more precise determination of career doses. Intensive efforts should be devoted to establishing a more reliable and practical method for risk estimation, such as probabilistic prediction in accordance with possible scenarios of astronaut behavior. Also, active dosimeter that can tell an astronaut the unexpected exposure to high dose radiation caused by solar particle event is desirable to be developed. Finally, ongoing efforts in the fields of radiation biology and medicine [39] [40] [41] [42] are no doubt important to reduce the large uncertainties associated with the biological effects of the HZE particles and their secondary radiations encountered in space. [43] [44] [45] 
